State FDA issues notice to eway outlet of Cafe Goodluck, revokes suspension of FC Road branch
FDA officials conducted an inspection at the outlet after a customer allegedly found a dead cockroach in an egg bhurji.
Tired of too many ads? go ad free now
"Based on initial inspection, we collected food samples from the outlet and sent them for testing at our labs.
We have asked them to furnish mandatory pest control records from the past, and internal, external audit reports," said Milind Mahangade, assistant commissioner, FDA, Raigad division.
The outlet continues to be operational for now. The cafe management was not reachable when contacted.
Meanwhile, the FDA has revoked the suspension of the FC Road outlet of the cafe after a re-inspection.
Earlier this month, the Pune FDA had suspended the licence of the outlet after a glass piece was allegedly found in a bun maska.
Suresh Annapure, joint commissioner, FDA (Pune), said, "Based on the re-inspection of Cafe Goodluck at FC Road, we have decided to revoke the licence suspension as they are compliant now with all the standards as per Schedule 4 of the Food Safety and Standards Act."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fashion Value Chain
8 hours ago
- Fashion Value Chain
Sold Out on Day One: India Can't Get Enough of McDonald's New ‘Protein Plus Slice'
McDonalds India (West & South), operated by Westlife Foodworld, witnessed unprecedented demand following the launch of its innovative Protein Plus Slice, with multiple outlets selling out of the new item on the very first day. The brand served more than 32,000 slices within 24 hours of launch, delivering approximately 160,000 grams of plant-based protein to customers across West and South India. Hon'ble FDA Min of Maharashtra, Shri Yogesh Kadam, Director – CSIR-CFTRI, along with the CEO and the MD of Westlife Foodworld at the launch event of McDonalds Protein Plus Slice The response was immediate and overwhelming, with customers eagerly customizing their favorite burgers with the protein enhancement. Mumbai led the region with over 11,000 slices sold, while Pune and Ahmedabad each surpassed 3,000 slices. Strong performance was also observed in Bengaluru and Chennai, with each exceeding 1,500 slices. The New Protein Plus Slice co-developed by CSIR-CFTRI The newly launched Protein Plus Range, features a first-of-its-kind 100% vegetarian, plant-based protein slice that adds 5 grams of protein to any burger. For the first time in the QSR industry, McDonalds is revolutionizing how people eat by allowing customers to add one, two, or even three slices to their favourite burgers, empowering them with greater nutritional choice without compromising taste. The launch event was inaugurated by Shri Yogesh Kadam, Honble Minister of State for FDA, Government of Maharashtra, who emphasized the growing need for safer and nutritious food choices that meet the needs of todays consumers. Developed in collaboration with the prestigious CSIR-Central Food Technological Research Institute (CFTRI), under the Ministry of Science & Technology, Government of India, the Protein Plus Slice contains no artificial colours or flavours and is free from onion and garlic, making it suitable for a wide range of dietary preferences. Akshay Jatia, Chief Executive Officer, Westlife Foodworld said, 'At McDonald's India, we have always believed in giving our customers more choice, and this time, we are giving them the power to personalize their protein intake. The Protein Plus Range allows them to enjoy their favourite McDonald's burgers without compromising on their protein needs or the taste. It also reflects our ongoing commitment to our 'Real Food, Real Good' philosophy, bringing together flavour, nutrition, and food science. We are grateful to CSIR-CFTRI for partnering with us to bring this forward-thinking product to life. Together, we remain committed to crafting menu items that are both wholesome and delicious, combining locally available ingredients in a way where great taste and nutrition go hand in hand.' Dr. Sridevi Annapurna Singh, Director, CSIR-CFTRI said, 'Building on our earlier success with the Multi-Millet Bun, we are excited to continue our partnership with McDonald's India to advance nutritional innovation in the QSR space. The Protein Plus slice is an outcome of science-backed formulation and a shared vision to elevate everyday meals through nutrition. This partnership showcases how industry and scientific institutions can come together to bring meaningful nutritional upgrades to mainstream eating.' This remarkable market response reinforces McDonalds Indias commitment to its Real Food, Real Good philosophy and demonstrates the brands leadership in menu innovation that genuinely addresses evolving consumer preferences. Customers across West and South can now savour their favourite burgers with the added nutritional goodness of protein, whether dining in, picking up via Drive-Thru, or ordering from the comfort of their homes through the McDelivery app. For more infromation, please visit:
Indian Express
a day ago
- Indian Express
Bengaluru's Empire restaurant found using banned colours for kebabs, health dept to initiate action
Bengaluru's renowned restaurant chain Empire has come under scrutiny from the Karnataka Health Department after tests revealed that chicken kebabs from several of its outlets were unsafe for consumption. Ambarish Gowda, Food Safety Officer, Food Safety and Standards Authority of India (FSSAI), inspected the Empire outlet near Anand Rao Circle on June 27 during a routine check, and collected 2 kilograms of chicken kebab samples for laboratory analysis. Later, the Authority collected more samples from six outlets, and all of them were declared as unsafe for consumption. Test results from the State Food Laboratory of the Public Health Institute, released on July 11, showed that the kebabs failed to meet the safety standards mandated under the Food Product Standards & Food Additives Regulations, 2011. Consequently, the food was officially declared unsafe under the Food Safety and Standards Act, 2006. Health Minister Dinesh Gundu Rao said there is a law prohibiting the use of Sunset Yellow. 'After getting to know about it in the past, we had warned them (Empire). However, they are using [the colour]. We again took the kebabs for tests from six of their outlets, and we will initiate action against them,' the minister said Sunday. Meanwhile, the Bruhat Bengaluru Mahanagara Palike (BBMP)'s Food Safety and Drug Administration (North Zone) has issued a formal notice requiring the restaurant to respond within 30 days. According to officials, Empire can request a retest of samples at the Central Food Technological Research Institute-Council of Scientific & Industrial Research (CSIR), Mysuru, at their own expense. When The Indian Express contacted Empire restaurant authorities, they said they would revert with their response to the issue. However, they are yet to respond at the time of publishing the news article. According to sources, the Empire outlets were using Sunset Yellow, an artificial colour for the kebabs, which is said to be harmful, especially among children. In June this year, the Karnataka Government banned the usage of artificial colours in chicken kebabs, fish and vegetarian food items across the state. As many as 39 kebab samples were collected from various parts of the state, and when tested, seven kebab samples had sunset yellow and one contained both sunset yellow and carmoisine. Thereafter, the department issued an order on June 21 stating, 'Such additives, as per the Food Safety and Standards Act, 2006, and the Food Safety and Standards (Food Products, Standards and Food Additives) Regulations, 2011, pose serious health risks to consumers.' The violation of the rules can lead to imprisonment ranging from a minimum of seven years up to a life term and a fine of up to Rs 10 lakh.
Time of India
a day ago
- Time of India
US targets knockoff weight-loss drugs
Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid mounting concerns over their potential safety risks. On Friday, a group of more than 80 bipartisan lawmakers asked the US Food and Drug Administration to stop counterfeit and copycat versions of GLP-1 drugs like Wegovy and Zepbound from flooding the market—a problem that emerged over the last year. 'We are concerned about recent reports revealing a surge in illegal and counterfeit anti-obesity medications,' they wrote in a letter to FDA commissioner Marty Makary. 'Undoubtedly, illegal counterfeit medications pose an increased risk to patient safety with sometimes fatal consequences.' The group—spearheaded by Representatives Richard Hudson of North Carolina and Herb Conaway of New Jersey—asked the agency to ramp up enforcement over illegally imported weight-loss drugs. They suggested issuing warning letters and better monitoring non-compliant online retailers and so-called compounding pharmacies that sell the medicines. The lawmakers also said the FDA should work in tandem with US Customs and Border Patrol agents to stop Chinese entities from shipping unsafe weight-loss drugs into the US. They requested an update on the FDA's efforts by July 30, given the 'urgency' of the situation. A spokesperson for the FDA said the agency will work with the US Department of Health and Human Services to provide a 'complete and thorough' response to the issues raised in the lawmakers' letter. 'Any effort to undermine America's supply of safe medicines is an issue that FDA takes seriously,' the spokesperson said. 'And we are deeply committed to strengthening the oversight of imported products at US ports of entry.' In recent years, the popularity of GLP-1 drugs has led to an explosion of copycats and counterfeits made by companies seeking to capitalise on the hype. State-licensed pharmacies were temporarily allowed to make copies of the drugs during a supply shortage but are no longer permitted to do so after Novo Nordisk and Eli Lilly boosted production. Still, some pharmacies have refused to wind down their operations while others have pivoted to selling the drugs in lower doses in order to avoid regulatory scrutiny. Counterfeit drugs are made by unregistered entities typically using illegally imported ingredients. As recently as April, there continue to be instances when counterfeit Ozempic pens covertly enter the drug supply chain undetected. Some patients are also purchasing ingredients directly from online sellers in an attempt to make the drugs themselves at home. In both cases, the medications don't go through the same rigorous approval process as brand-name drugs made by Novo and Lilly. Experts worry the lack of oversight is putting patients at risk. The FDA has said it's aware of hospitalisations potentially linked to the copycat drugs, but that adverse events are likely being underreported. 'We support the bi-partisan call for the FDA to crack down on counterfeit and illegally sold weight-loss drugs,' said a spokesperson for Hims & Hers Health , one of the telehealth firms that sells compounded GLP-1s. 'We appreciate lawmakers' recognition that legitimate compounded medications dispensed by state-regulated pharmacies are not counterfeit. Patient safety must always come first.' Novo and Lilly have discouraged consumers from using compounded and counterfeit products, including suing telehealth firms that sell the copycat versions and working with border agents to seize illegal shipments.
